Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma

Overview

Journal Nutrients

Date 2020 Jun 3

PMID 32481552

Citations 32

Authors

Daisuke Uchida

Akinobu Takaki

Atsushi Oyama

Takuya Adachi

Nozomu Wada

Hideki Onishi

Hiroyuki Okada

Affiliations

Soon will be listed here.

Abstract

Chronic viral hepatitis B and C and non-alcoholic fatty liver disease (NAFLD) have been widely acknowledged to be the leading causes of liver cirrhosis and hepatocellular carcinoma. As anti-viral treatment progresses, the impact of NAFLD is increasing. NAFLD can coexist with chronic viral hepatitis and exacerbate its progression. Oxidative stress has been recognized as a chronic liver disease progression-related and cancer-initiating stress response. However, there are still many unresolved issues concerning oxidative stress, such as the correlation between the natural history of the disease and promising treatment protocols. Recent findings indicate that oxidative stress is also an anti-cancer response that is necessary to kill cancer cells. Oxidative stress might therefore be a cancer-initiating response that should be down regulated in the pre-cancerous stage in patients with risk factors for cancer, while it is an anti-cancer cell response that should not be down regulated in the post-cancerous stage, especially in patients using anti-cancer agents. Antioxidant nutrients should be administered carefully according to the patients' disease status. In this review, we will highlight these paradoxical effects of oxidative stress in chronic liver diseases, pre- and post-carcinogenesis.

Citing Articles

Glutathione and Selenium Supplementation Attenuates Liver Injury in Diethylnitrosamine-Induced Hepatocarcinogenic Mice by Enhancing Glutathione-Related Antioxidant Capacities.

Hsiao Y, Huang S, Cheng S, Hsu C, Huang Y Int J Mol Sci. 2024; 25(21).

PMID: 39518894 PMC: 11546938. DOI: 10.3390/ijms252111339.

Metformin: Beyond Type 2 Diabetes Mellitus.

Ahmad R, Haque M Cureus. 2024; 16(10):e71730.

PMID: 39421288 PMC: 11486535. DOI: 10.7759/cureus.71730.

Oxidative stress-induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk.

Gitto S, Fiorillo C, Argento F, Fini E, Borghi S, Falcini M Res Pract Thromb Haemost. 2024; 8(6):102555.

PMID: 39309232 PMC: 11416524. DOI: 10.1016/j.rpth.2024.102555.

Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer.

Cristani M, Citarella A, Carnamucio F, Micale N Biomolecules. 2024; 14(8).

PMID: 39199418 PMC: 11352298. DOI: 10.3390/biom14081031.

An Oxidative Stress-Related Prognostic Signature Predicts Treatment Response and Outcomes for Hepatocellular Carcinoma After Transarterial Chemoembolization.

Ma H, Yu T, Li Z, Zhang L, Chen R, Ren Z J Hepatocell Carcinoma. 2024; 11:1569-1580.

PMID: 39156675 PMC: 11330244. DOI: 10.2147/JHC.S465592.

References

Stamoulis I, Kouraklis G, Theocharis S . Zinc and the liver: an active interaction. Dig Dis Sci. 2007; 52(7):1595-612. DOI: 10.1007/s10620-006-9462-0. View

Dewidar B, Meyer C, Dooley S, Meindl-Beinker A . TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells. 2019; 8(11). PMC: 6912224. DOI: 10.3390/cells8111419. View

Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D . Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol. 2016; 66(1):212-227. DOI: 10.1016/j.jhep.2016.07.009. View

Goda K, Muta K, Yasui Y, Oshida S, Kitatani K, Takekoshi S . Selenium and Glutathione-Depleted Rats as a Sensitive Animal Model to Predict Drug-Induced Liver Injury in Humans. Int J Mol Sci. 2019; 20(13). PMC: 6652140. DOI: 10.3390/ijms20133141. View

Singal A, Lim J, Kanwal F . AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review. Gastroenterology. 2019; 156(8):2149-2157. PMC: 6529246. DOI: 10.1053/j.gastro.2019.02.046. View

Rebbani K, Tsukiyama-Kohara K . HCV-Induced Oxidative Stress: Battlefield-Winning Strategy. Oxid Med Cell Longev. 2016; 2016:7425628. PMC: 4880679. DOI: 10.1155/2016/7425628. View

Pinter M, Peck-Radosavljevic M . Review article: systemic treatment of hepatocellular carcinoma. Aliment Pharmacol Ther. 2018; 48(6):598-609. PMC: 6120553. DOI: 10.1111/apt.14913. View

Winther K, Papini E, Attanasio R, Negro R, Hegedus L . A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Hashimoto's Thyroiditis. Eur Thyroid J. 2020; 9(2):99-105. PMC: 7109430. DOI: 10.1159/000504781. View

Seki E, Brenner D, Karin M . A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology. 2012; 143(2):307-20. PMC: 3523093. DOI: 10.1053/j.gastro.2012.06.004. View

10.

Lee H, Park S, Lee M, Lee E, Lee J, Kim S . An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia. Liver Int. 2020; 40(7):1736-1743. DOI: 10.1111/liv.14451. View

11.

Loguercio C, De Girolamo V, Federico A, Feng S, Crafa E, Cataldi V . Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease. Biol Trace Elem Res. 2001; 81(3):245-54. DOI: 10.1385/BTER:81:3:245. View

12.

Kato N, Yoshida H, Ono-Nita S, Kato J, Goto T, Otsuka M . Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology. 2000; 32(2):405-12. DOI: 10.1053/jhep.2000.9198. View

13.

Rahmani Z, Huh K, Lasher R, Siddiqui A . Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol. 2000; 74(6):2840-6. PMC: 111774. DOI: 10.1128/jvi.74.6.2840-2846.2000. View

14.

Ivancovsky-Wajcman D, Fliss-Isakov N, Salomone F, Webb M, Shibolet O, Kariv R . Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease. Dig Liver Dis. 2019; 51(12):1698-1705. DOI: 10.1016/j.dld.2019.06.005. View

15.

Liao Z, Chen L, Zhang X, Zhang H, Tan X, Dong K . PTPRε Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-β Receptor 1. Hepatology. 2020; 72(3):997-1012. DOI: 10.1002/hep.31104. View

16.

Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y . Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition. 2006; 23(1):46-52. DOI: 10.1016/j.nut.2006.09.004. View

17.

Higuchi T, Moriyama M, Fukushima A, Matsumura H, Matsuoka S, Kanda T . Association of mRNA expression of iron metabolism-associated genes and progression of non-alcoholic steatohepatitis in rats. Oncotarget. 2018; 9(40):26183-26194. PMC: 5995254. DOI: 10.18632/oncotarget.25488. View

18.

DAmbrosio R, Aghemo A, Rumi M, Ronchi G, Donato M, Paradis V . A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis. Hepatology. 2012; 56(2):532-43. DOI: 10.1002/hep.25606. View

19.

Muriel P . Role of free radicals in liver diseases. Hepatol Int. 2009; 3(4):526-36. PMC: 2790593. DOI: 10.1007/s12072-009-9158-6. View

20.

Salomone F, Barbagallo I, Godos J, Lembo V, Currenti W, Cina D . Silibinin Restores NAD⁺ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver. Nutrients. 2017; 9(10). PMC: 5691703. DOI: 10.3390/nu9101086. View